Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01828112
Title LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site Fayetteville Arkansas 72703 United States Details
Novartis Investigative Site Hollywood Florida 33021 United States Details
Novartis Investigative Site Jacksonville Florida 32256 United States Details
Novartis Investigative Site Miami Florida 33136 United States Details
Novartis Investigative Site Maywood Illinois 60153 United States Details
Novartis Investigative Site Iowa City Iowa 52242 United States Details
Novartis Investigative Site Boston Massachusetts 02114 United States Details
Novartis Investigative Site Tulsa Oklahoma 74136 United States Details
Novartis Investigative Site Nashville Tennessee 37203 United States Details
Novartis Investigative Site Sugar Land Texas 77479 United States Details
Novartis Investigative Site Waco Texas 76712 United States Details
Novartis Investigative Site Fairfax Virginia 22031 United States Details
Novartis Investigative Site Seattle Washington 98104 United States Details
Novartis Investigative Site Edegem Antwerpen 2650 Belgium Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Marseille cedex 20 Bouches Du Rhone 13915 France Details
Novartis Investigative Site Le Mans Cedex 09 72037 France Details
Novartis Investigative Site Besancon cedex 25030 France Details
Novartis Investigative Site Brest 29200 France Details
Novartis Investigative Site Caen 14021 France Details
Novartis Investigative Site Mulhouse cedex 68070 France Details
Novartis Investigative Site Paris 75970 France Details
Novartis Investigative Site Strasbourg F 67085 France Details
Novartis Investigative Site Suresnes 92150 France Details
Novartis Investigative Site Bad Berka 99437 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Esslingen 73730 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Koeln 51109 Germany Details
Novartis Investigative Site Tuebingen 72076 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Limerick Co Limerick V94 YX29 Ireland Details
Novartis Investigative Site Dublin 4 D04 Ireland Details
Novartis Investigative Site Kfar Saba 4428164 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Avellino AV 83100 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Pisa PI 56124 Italy Details
Novartis Investigative Site Aviano PN 33081 Italy Details
Novartis Investigative Site Reggio Emilia RE 42123 Italy Details
Novartis Investigative Site Roma RM 00189 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Fukuoka city Fukuoka 812-8582 Japan Details
Novartis Investigative Site Fukuoka-city Fukuoka 811-1395 Japan Details
Novartis Investigative Site Akashi Hyogo 673-8558 Japan Details
Novartis Investigative Site Okayama-city Okayama 700-8558 Japan Details
Novartis Investigative Site Hirakata-city Osaka 573-1191 Japan Details
Novartis Investigative Site Osaka Sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Osaka-city Osaka 541-8567 Japan Details
Novartis Investigative Site Takatsuki-city Osaka 569-8686 Japan Details
Novartis Investigative Site Koto ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Niigata 951 8520 Japan Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Lisboa 1649 035 Portugal Details
Novartis Investigative Site Moscow Region Istra Village 143423 Russian Federation Details
Novartis Investigative Site Moscow 115478 Russian Federation Details
Novartis Investigative Site Saint Petersburg 197022 Russian Federation Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Madrid Andalucia 28046 Spain Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Cataluña 08028 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Madrid 28222 Spain Details
Novartis Investigative Site Luzern 6000 Switzerland Details
Novartis Investigative Site St. Gallen 9007 Switzerland Details
Novartis Investigative Site Istanbul TUR 34098 Turkey Details
Novartis Investigative Site Ankara 06100 Turkey Details
Novartis Investigative Site Pendik Istanbul 34899 Turkey Details
Novartis Investigative Site Cheltenham Gloucestershire GL53 7AN United Kingdom Details
Novartis Investigative Site Hants Southampton SO9 5NY United Kingdom Details
Novartis Investigative Site Aberdeen AB25 2ZN United Kingdom Details
Novartis Investigative Site Leicester LE1 5WW United Kingdom Details
Novartis Investigative Site London SE1 9RT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field